Waters Medical Systems
Leading designer, manufacturer and marketer of organ preservation and whole blood oximetry products. The RM3 Renal Preservation System uses pulsatile perfusion technology to regulate the pressure, flow and temperature of the kidneys prior to transplant. Oxicom whole blood oximeters provide data on the oxygen saturation of the patient’s blood.

FY2004 Highlights
Fiscal Year 2004 Sales: $2.6 million

13th consecutive year of profitability.

Received CE Mark for Oxicom products.

Introduced new RM3 single kidney cassette.

Independent scientific research strongly recommends pulsatile preservation as the standard for renal preservation.

Pulsatile Preservation
Waters Medical Systems has been the leader in pulsatile preservation technology since 1971. With over 55,000 patients in the United States waiting to receive a kidney transplant, the RM3 renal perfusion device maintains kidney function between the time of recovery and transplantation. The state-of-the-art alternative to cold storage, the RM3 provides medical teams with organ performance data, potentially expanding the organ donor pool. Perfusion with the RM3 results in improved kidney function, shorter hospital stays, speedier patient recovery and reduced health care costs.

As always, Waters continues to be an active participant in the organ transplant community. During the year, the company established an award to recognize those who have increased the understanding and/or advancement of organ preservation. Known as the ‘Waters Medical Systems Preservation Award,’ it will be presented to an individual or group at the International Society for Organ Preservation’s annual Wetlab/Symposium.

For more information,
please visit
www.watersmed.com

Whole Blood Oximetry
Through its Medical Systems division, Waters is also the leading designer, manufacturer and marketer of whole blood oximetry products. Since 1988, the division’s Oxicom® family of whole blood oximeters has been the worldwide leader in cardiac catheterization laboratories. And with over a half-million saturation samples measured every year, the Oxicom series is a proven system and a vital part of any cardiac catheterization lab.

In June 2004, Waters received the CE Mark for its Oxicom 2100 and 3000 whole blood oximeters, which will enable the company to sell the products to the 25 European Union and three European Free Trade Association member states. The division’s RM3 renal perfusion devices received the CE Mark in 1999. The designations will enable Waters to distribute both of these product lines throughout the European marketplace.